Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines

Abstract

We identified CAVEOLIN-1 as a candidate for a tumour suppressor gene mapping to human chromosome 7q31.1. A number of studies suggest that caveolin could function as a tumour suppressor. Expression of caveolin, and in turn the number of caveolae within a cell, are inversely correlated with the transforming ability of numerous oncoproteins, including H-ras, v-abl, and bcr-abl, and caveolin is a major transformation-dependent substrate of v-src. Heterologous expression of caveolin has been shown to abrogate anchorage-independent growth and induce apoptosis in transformed fibroblasts and also to suppress anchorage-independent growth in human mammary carcinoma cells. We have analysed the status and expression of the human CAVEOLIN-1 gene in primary tumours and tumour-derived cell lines. We found no evidence for mutation of CAVEOLIN-1 in human cancers. Additionally, we found that while the first two exons of CAVEOLIN-1 are associated with a CpG island, this is not methylated in either primary tumours or in tumour-derived cell lines in which Caveolin-1 expression is low or undetectable. The level of expression of Caveolin-1 does not correlate with loss of heterozygosity at the CAVEOLIN-1 locus in these same cell lines. Contrary to other published studies, we have shown that CAVEOLIN-1 is not expressed in normal breast ductal epithelial cells in vivo. CAVEOLIN-1 is however highly expressed in breast myoepithelial cells and its expression is retained in tumours derived from breast myoepithelium. Together our data refute a role for CAVEOLIN-1 as a breast tumour suppressor gene in vivo.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M and Scarpa A. . 1996 Cancer Res. 56: 3808–3813.

  • Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R and Lidereau R. . 1992 Lancet 339: 139–143.

  • Bilderback TR, Grigsby RJ and Dobrowsky RT. . 1997 J. Biol. Chem. 272: 10922–10927.

  • Bird AP. . 1986 Nature 321: 209–213.

  • Cuthbert AP, Trott DA, Ekong RM, Jezzard S, England NL, Themis M, Todd CM and Newbold RF. . 1995 Cytogenet. Cell. Genet. 71: 68–76.

  • Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T and Lisanti MP. . 1997 J. Biol. Chem. 272: 16374–16381.

  • Fan JY, Carpentier JL, van Obberghen E, Grunfeld C, Gorden P and Orci L. . 1983 J. Cell. Sci. 61: 219–230.

  • Fra AM, Masserini M, Palestini P, Sonnino S and Simons K. . 1995 FEBS Lett. 375: 11–14.

  • Garcia-Cardena G, Fan R, Stern DF, Liu J and Sessa WC. . 1996 J. Biol. Chem. 271: 27237–27240.

  • Gardiner-Garden M and Frommer M. . 1987 J. Mol. Biol. 196: 261–282.

  • Glenney JR Jr. . 1989 J. Biol. Chem. 264: 20163–20166.

  • Glenney JR Jr and Soppet D. . 1992 Proc. Natl. Acad. Sci. USA 89: 10517–10521.

  • Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. . 1995 Cancer Res. 55: 4525–4530.

  • Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and deJong PJ. . 1994 Nat. Genet. 6: 84–89.

  • Kerr J, Leary JA, Hurst T, Shih YC, Antalis TM, Friedlander M, Crawford E, Khoo SK, Ward B and Chenevix-Trench G. . 1996 Oncogene 13: 1815–1818.

  • Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N and Koeffler HP. . 1997 Genes Chromosomes Cancer 19: 1–5.

  • Koleske AJ, Baltimore D and Lisanti MP. . 1995 Proc. Natl. Acad. Sci. USA 92: 1381–1385.

  • Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Akama Y, Kitahara K, Fujii K and Tahara E. . 1994 Int. J. Cancer 59: 597–600.

  • Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M and Simons K. . 1992 J. Cell. Biol. 118: 1003–1014.

  • Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R and Berns A. . 1991 Nucleic Acids Res. 19: 4293.

  • Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE. . 1998 Oncogene 16: 1391–1397.

  • Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I and Lisanti MP. . 1995 J. Biol. Chem. 270: 15693–15701.

  • Li S, Couet J and Lisanti MP. . 1996 J. Biol. Chem. 271: 29182–29190.

  • Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF and Sargiacomo M. . 1994 J. Cell. Biol. 126: 111–126.

  • Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, Frame MC and Parkinson EK. . 1996 Oncogene 13: 561–568.

  • Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, Edington KG, Ly IS, Simmons R, Haw R, Black DM, Newbold RF and Parkinson EK. . 1997 Oncogene 14: 1955–1964.

  • Maniatis T, Fritsch EF and Sambrook J. . 1989 Molecular Cloning: A Laboratory Manual (2nd Ed.). Cold Spring Harbour Laboratory Press.

    Google Scholar 

  • Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV and Simons K. . 1995 Proc. Natl. Acad. Sci. USA 92: 10339–10343.

  • Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M and Oishi M. . 1993 Mol. Cell. Biol. 13: 6036–6043.

  • Pereira-Smith OM and Smith JR. . 1988 Proc. Natl. Acad. Sci. USA 85: 6042–6046.

  • Reese MG, Harris NL and Eeckman FH. . 1996 In: Large Scale Sequencing: Specific Neural Networks for Promoter and Splice Site Recognition. Proceedings of the Pacific Symposium on Biocomputing. Larry Hunter and Terri Klein (eds).. Kona, Hawaii.

    Google Scholar 

  • Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR and Anderson RG. . 1992 Cell 68: 673–682.

  • Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm K, Chen Z, Hendrix MJ and Pemberton P et al. 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 537–546.

  • Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF and Lisanti MP. . 1995 J. Biol. Chem. 270: 16395–16401.

  • Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF and Lisanti MP. . 1996 Proc. Natl. Acad. Sci. USA 93: 131–135.

  • Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, Bentolila S, Birren BB, Butler A, Castle AB, Chiannilkulchai N, Chu A, Clee C, Cowles S, Day PJ, Dibling T, Drouot N, Dunham I, Duprat S, East C and Hudson TJ et al. 1996 Science 274: 540–546.

  • Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J and Smith DI. . 1997 Oncogene 15: 2727–2733.

  • Song SK, Li Shengwen Okamoto T, Quilliam LA, Sargiacomo M and Lisanti MP. . 1996 J. Biol. Chem. 271: 9690–9697.

  • Stahl A and Mueller BM. . 1995 J. Cell. Biol. 129: 335–344.

  • Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN and Jenkins RB. . 1995 Cancer Res. 55: 4114–4119.

  • Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF and Lisanti MP. . 1996 J. Biol. Chem. 271: 2255–2261.

  • Venable ME, Lee JY, Smyth MJ, Bielawska A and Obeid LM. . 1995 J. Biol. Chem. 270: 30701–30708.

  • Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE and Giancotti FG. . 1996 Cell 87: 733–743.

  • Zenklusen JC, Bieche I, Lidereau R and Conti CJ. . 1994a Proc. Natl. Acad. Sci. USA 91: 12155–12158.

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. . 1994b Cancer Res. 54: 6370–6373.

  • Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ. . 1995a Cancer Res. 55: 1347–1350.

  • Zenklusen JC, Weitzel JN, Ball HG and Conti CJ. . 1995b Oncogene 11: 359–363.

  • Zenklusen JC and Conti CJ. . 1996 Mol. Carcinog. 15: 167–175.

  • Zenklusen JC, Rodriguez LV, LaCava M, Wang Z, Goldstein LS and Conti CJ. . 1996 Genome Res. 6: 1070–1076.

  • Zenklusen JC, Hodges LC and Conti CJ. . 1997 Oncogene 14: 109–114.

Download references

Acknowledgements

This work has been supported by grants from the Cancer Research Campaign (CRC) of the United Kingdom and the Association for International Cancer Research (AICR).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hurlstone, A., Reid, G., Reeves, J. et al. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 18, 1881–1890 (1999). https://doi.org/10.1038/sj.onc.1202491

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202491

Keywords

This article is cited by

Search

Quick links